Phenomenology, Structure, and Dynamic of Psychedelic States
- PMID:28025814
- DOI: 10.1007/7854_2016_459
Phenomenology, Structure, and Dynamic of Psychedelic States
Erratum in
- Erratum to: Phenomenology, Structure, and Dynamic of Psychedelic States.Preller KH, Vollenweider FX.Preller KH, et al.Curr Top Behav Neurosci. 2018;36:1. doi: 10.1007/7854_2017_477.Curr Top Behav Neurosci. 2018.PMID:28710675No abstract available.
Abstract
Classic serotonergic hallucinogens or psychedelics produce an altered states of consciousness (ASC) that is characterized by profound alterations in sensory perception, mood, thought including the perception of reality, and the sense of self. Over the past years, there has been considerable progress in the search for invariant and common features of psychedelic states. In the first part of this review, we outline contemporary approaches to characterize the structure of ASCs by means of three primary etiology-independent dimensions including oceanic boundlessness, anxious ego-dissolution, and visionary restructuralization as well as by 11 lower-order factors, all of which can be reliably measured by the altered state of consciousness questionnaire (APZ-OAV). The second part sheds light on the dynamic nature of psychedelic experiences. Frequently, psychedelic subjects progress through different stages over time and levels of changes along a perception-hallucination continuum of increasing arousal and ego-dissolution. We then review in detail the acute effects of psychedelics on sensory perception, emotion, cognition, creativity, and time perception along with possible neural mechanisms underlying them. The next part of this review outlines the influence of non-pharmacological factors (predictors) on the acute psychedelic experience, such as demographics, genetics, personality, mood, and setting, and also discusses some long-term effects succeeding the acute experience. The last part presents some recent concepts and models attempting to understand different facets of psychedelic states of consciousness from a neuroscientific perspective.
Keywords: Altered states of consciousness; Hallucinogens; Human; Lysergic acid diethylamide (LSD); Psilocybin; Psychedelics; Serotonin.
Similar articles
- Dreams and Psychedelics: Neurophenomenological Comparison and Therapeutic Implications.Kraehenmann R.Kraehenmann R.Curr Neuropharmacol. 2017;15(7):1032-1042. doi: 10.2174/1573413713666170619092629.Curr Neuropharmacol. 2017.PMID:28625125Free PMC article.Review.
- The standardized psychometric assessment of altered states of consciousness (ASCs) in humans.Dittrich A.Dittrich A.Pharmacopsychiatry. 1998 Jul;31 Suppl 2:80-4. doi: 10.1055/s-2007-979351.Pharmacopsychiatry. 1998.PMID:9754838Review.
- Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics.Hovmand OR, Poulsen ED, Arnfred S.Hovmand OR, et al.J Psychopharmacol. 2024 Jan;38(1):19-32. doi: 10.1177/02698811231200019. Epub 2023 Nov 16.J Psychopharmacol. 2024.PMID:37969069Free PMC article.Review.
- Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution.Tagliazucchi E, Roseman L, Kaelen M, Orban C, Muthukumaraswamy SD, Murphy K, Laufs H, Leech R, McGonigle J, Crossley N, Bullmore E, Williams T, Bolstridge M, Feilding A, Nutt DJ, Carhart-Harris R.Tagliazucchi E, et al.Curr Biol. 2016 Apr 25;26(8):1043-50. doi: 10.1016/j.cub.2016.02.010. Epub 2016 Apr 13.Curr Biol. 2016.PMID:27085214Clinical Trial.
- Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.Varley TF, Carhart-Harris R, Roseman L, Menon DK, Stamatakis EA.Varley TF, et al.Neuroimage. 2020 Oct 15;220:117049. doi: 10.1016/j.neuroimage.2020.117049. Epub 2020 Jun 30.Neuroimage. 2020.PMID:32619708
Cited by
- The Evolved Psychology of Psychedelic Set and Setting: Inferences Regarding the Roles of Shamanism and Entheogenic Ecopsychology.Winkelman MJ.Winkelman MJ.Front Pharmacol. 2021 Feb 23;12:619890. doi: 10.3389/fphar.2021.619890. eCollection 2021.Front Pharmacol. 2021.PMID:33732156Free PMC article.Review.
- "Hallucinations" Following Acute Cannabis Dosing: A Case Report and Comparison to Other Hallucinogenic Drugs.Barrett FS, Schlienz NJ, Lembeck N, Waqas M, Vandrey R.Barrett FS, et al.Cannabis Cannabinoid Res. 2018 Mar 1;3(1):85-93. doi: 10.1089/can.2017.0052. eCollection 2018.Cannabis Cannabinoid Res. 2018.PMID:29682608Free PMC article.
- Cognitive functioning associated with acute and subacute effects of classic psychedelics and MDMA - a systematic review and meta-analysis.Basedow LA, Majić T, Hafiz NJ, Algharably EAE, Kreutz R, Riemer TG.Basedow LA, et al.Sci Rep. 2024 Jun 26;14(1):14782. doi: 10.1038/s41598-024-65391-9.Sci Rep. 2024.PMID:38926480Free PMC article.
- Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.Breeksema JJ, Niemeijer AR, Krediet E, Vermetten E, Schoevers RA.Breeksema JJ, et al.CNS Drugs. 2020 Sep;34(9):925-946. doi: 10.1007/s40263-020-00748-y.CNS Drugs. 2020.PMID:32803732Free PMC article.
- Psychedelics and fNIRS neuroimaging: exploring new opportunities.Scholkmann F, Vollenweider FX.Scholkmann F, et al.Neurophotonics. 2023 Jan;10(1):013506. doi: 10.1117/1.NPh.10.1.013506. Epub 2022 Dec 2.Neurophotonics. 2023.PMID:36474478Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous